(1) The results of the 2023 co-optation of academicians of the Chinese Academy of Sciences and the Chinese Academy of Sciences will be announced
Recently, the Chinese Academy of Sciences and the Chinese Academy of Engineering respectively announced the results of the 2023 academician co-optation. According to the published data, 59 academicians were elected by the Chinese Academy of Sciences and 74 academicians by the Chinese Academy of Engineering, with a total of 133 new academicians added to the two academies. This result has further expanded the ranks of academicians in China, and the total number of academicians of the Chinese Academy of Sciences and the Chinese Academy of Engineering is now 873 and 978.
(2) The results of the co-optation of academicians reflect the inclination in the field of scientific research
This time, the number of co-opted academicians is further tilted towards key fields, basic disciplines, emerging disciplines and interdisciplinary disciplines urgently needed by the country. At the same time, it is also inclined to undertake major national scientific research tasks, major scientific and technological infrastructure construction and major projects and make outstanding contributions to scientific researchers, as well as scientific research personnel who have made outstanding contributions to national defense and national defense. This inclined strategy can better promote the development of related research fields and improve the overall level of scientific and technological innovation in China.
(3) The distribution of disciplines of new academicians
According to statistics, the research fields of the new academicians of the Chinese Academy of Engineering this year cover 43 first-level disciplines, covering 78 disciplines in the guidelines for the co-optation of academicians of the Chinese Academy of Engineering2%。This shows China's scientific research strength and achievements in various disciplines. In particular, a total of 11 experts from the Faculty of Life Sciences and Medicine were elected, whose research results will have a positive impact on the cause of medicine and the health of the people in our country.
(4) Huo Yong sued Hu Dayi after being elected as an academician
In this academician election, Professor Huo Yong was unsuccessful in his election and was unsuccessful in the election of an academician. However, he did not give up and formally sued Hu Dayi, director of the heart center of Peking University People's Hospital. Previously, there was a report alleging that Professor Huo Yong had academic misconduct and irregularities, and this report affected the results of Professor Huo Yong's academician selection. Professor Huo Yong disputed the accusations and said that the whistleblower would be held accountable through legal channels.
(1) Professor Huo Yong's academic achievements and contributions
Professor Huo Yong is the Director of the Department of Cardiology and Cardiology Center of Peking University First Hospital, and a well-known cardiologist in China. He has published more than 200 academic articles and edited 28 academic monographs. His research results have played an important role in the prevention and clinical practice of heart disease. Although he was not elected as a Fellow, his influence and contributions in the academic field cannot be ignored.
(2) Professor Hu Dayi's outstanding contributions and achievements
Professor Hu Dayi is one of the top experts in the field of cardiology in China. As a candidate for the Nobel Prize in Physiology or Medicine, he is the first medical expert in China to use radiofrequency ablation** for tachyarrhythmias. He also pioneered the "coronary stent" technology and is known as the "father of coronary stents in China". Professor Hu has published more than 3,400 first-class and popular science articles, edited and translated more than 60 medical works, and has made important contributions to the research and development of cardiovascular diseases.
(1) Strictness of academic competition and selection criteria
Both Huo Yong and Hu Dayi are well-known experts in the field of medicine, and their extensive experience and outstanding contributions make them candidates for academicians. However, in the process of selecting academicians, the final results are not always satisfactory due to reports and other reasons. The selection criteria for academicians are strict, and the opposition of other candidates or reports from opponents is likely to affect the selection results. In this context, the decision to prosecute the whistleblower can be understood as a choice made by Professor Huo Yong in order to defend his academic reputation and rights, as well as his dissatisfaction with the selection results.
(2) The necessity of resolving disputes through law
In the face of disputes and disputes in academic competition, it may be the best option to resolve them through legal means. Through the legal process, the authenticity and legitimacy of the report can be reviewed and the dispute can be ensured to be handled fairly and fairly. At the same time, the intervention of the law can ensure that the resolution of disputes complies with the provisions and procedures of the law, avoid the interference of personal emotions and prejudices, and safeguard the public interest and the reputation of the academic community.
The selection of academicians is one of the highest honors in China's scientific research community, and obtaining this honor is an extremely challenging goal for scientific researchers. Different academic perspectives, research outputs, and personal backgrounds often lead to controversy and conflict. In dealing with these disputes and conflicts, the principles of science and law should be respected, and disputes should be resolved through due process and legal means to ensure the fairness and accuracy of the selection process and safeguard the reputation and overall interests of the academic community. At the same time, we should attach great importance to people's attention to the results of the selection of academicians, and maintain an objective, fair and rational attitude to promote the progress of China's scientific and technological innovation and academic development.